AB287091
MW 538.7 Da, Purity >98%. A competitive antagonist of transmembrane glutamine flux, that selectively targets the amino acid transporter ASCT2 (SLC1A5). V-9302 inhibits ASCT2-mediated glutamine uptake (IC50 = 9.6 μM) in HEK-293 cells.
Product details
This product is manufactured by BioVision, an Abcam company and was previously called B2563 V-9302. B2563-5 is the same size as the 5 mg size of ab287091.
Properties and storage information
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store in the dark
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Nature medicine 24:194-202 PubMed29334372
2018
Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models.
Applications
Unspecified application
Species
Unspecified reactive species
Michael L Schulte,Allie Fu,Ping Zhao,Jun Li,Ling Geng,Shannon T Smith,Jumpei Kondo,Robert J Coffey,Marc O Johnson,Jeffrey C Rathmell,Joe T Sharick,Melissa C Skala,Jarrod A Smith,Jordan Berlin,M Kay Washington,Michael L Nickels,H Charles Manning
Bioorganic & medicinal chemistry letters 26:1044-1047 PubMed26750251
2016
2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport.
Applications
Unspecified application
Species
Unspecified reactive species
Michael L Schulte,Alexandra B Khodadadi,Madison L Cuthbertson,Jarrod A Smith,H Charles Manning
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com